Delivering the Next Evolution of Healthcare

Recombinetics is a recognized leader in animal gene editing and associated applied technologies for biomedical research, regenerative medicine and animal agriculture.

We leverage our proprietary gene editing platform to commercialize and deploy technologies through our BioVentures that pivotally impact human health and longevity and add value to farm animals.

Gene Editing
Girls getting better
One Platform, all Industries.

Groundbreaking Technology for Animal Ag and Biomedicine

Recombinetics’ gene editing platform is the foundation of our BioVentures and core services studio. Our BioVentures arise from in-house and externally developed opportunities that depend on gene edited large animals to disrupt their industries. We also mobilize the platform by offering preclinical services in custom gene edited models that can supplement or reduce the reliance on nonhuman primates in preclinical research.


> 3,000

clinical trials for cell and gene therapies in past 5 years
Mouse DNA icon


of all clinical trials fail
Skinny cow icon


Smallholders need more efficient animals to produce healthy protein
Regenerative medicine

Transforming Tissue Regeneration

We are engineering biologics initially focused on Hernia repair. Sarxion Biologics’ ECM material has improved integration and healing.

preclinical research

Bringing Precision Medicine to Brain Tumors

We are a clinical-stage neuro-oncology therapeutics company bringing precision medicine to patients with Glioblastoma (GBM) and Neurofibromatosis Types 1 and 2 (NF1 and NF2).

precision breeding

Producing Healthier, Happier Animals and More Sustainable Farming

We use state-of-the-art breeding methods to precisely deliver traits that improve the health, welfare and sustainability of food animals to feed a hungry world while protecting the environment.

notable news

Swine Reporter Models For Somatic Cell Gene Editing

We’re in Baltimore for ASGCT 2024! Stop by poster #517 on Wednesday, May 8th at 5:30 EST to hear from Jarryd Campbell about our swine reporter models for somatic cell genome editing. We are looking forward to making some new connections and meeting up with old colleagues.

Your investment can help us change the world.

Reach out today for information on how you can make a difference.